Gene therapy for human genetic disease?

Area of Science:

• Biotechnology and Genetic Engineering
• Molecular Biology
• Medical Ethics

Background:

• Gene therapy offers potential for treating human genetic diseases.
• Significant knowledge gaps exist in gene regulation, genetic recombination, and the molecular basis of genetic diseases.
• The short- and long-term side effects of gene therapy are largely unknown.

Purpose of the Study:

• To advocate for continued research into gene therapy techniques.
• To propose the establishment of ethicoscientific criteria for gene therapy development and application.
• To caution against premature human gene therapy trials due to current scientific limitations.

Main Methods:

• Review of existing literature and recent experimental findings.
• Analysis of studies demonstrating directed genetic modification in mammalian cells.
• Discussion of the implications of these findings for future gene therapy feasibility.

Main Results:

• Recent studies show successful genetic modification in mammalian cells, including restoring enzyme activity (thymidine kinase, alpha-D-galactose-l-phosphate uridyltransferase).
• Evidence suggests that genetic modifications may be heritable or persistent after cell culture.
• These advancements technically enhance the prospects for gene therapy.

Conclusions:

• While gene therapy shows future potential, current understanding of human genetic processes and safety is insufficient for clinical application.
• Development of comprehensive ethicoscientific criteria is crucial to guide responsible gene therapy research and prevent misuse.
• Continued research is supported, but human trials should be deferred until safety and efficacy are better established.